FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today that it is scheduled to present at the Collins Steward Fourth Annual Growth Conference on Thursday, July 10, 2008. John Mordock, Neurologix President and Chief Executive Officer, will discuss the company’s business strategy and corporate overview from 10:00 – 10:30 am (ET) at the Mandarin Oriental Hotel in New York City.
